MEN1-associated primary hyperparathyroidism in the Spanish Registry: clinical characterictics and surgical outcomes. Issue 10 (October 2019)

• Record Type: Journal Article
• Authors: Lamas, Cristina; Navarro, Elena; Casterás, Anna; Portillo, Paloma; Alcázar, Victoria; Calatayud, María; Álvarez-Escolá, Cristina; Sastre, Julia; Boix, Evangelina; Forga, Lluis; Vicente, Almudena; Oriola, Josep; Mesa, Jordi; Valdés, Nuria
• Is Part Of: Endocrine connections. Volume 8:Issue 10(2019)
• Page Start: 1416
• Page End: 1424
• Publication Date: 2019-10
• Subjects: multiple endocrine neoplasia type 1 -- MEN1 gene -- primary hyperparathyroidism -- parathyroidectomy -- hypoparathyroidism; Endocrinology -- Periodicals; 616.4005
• DOI: 10.1530/EC-19-0321
• Languages: English
• ISSNs: 2049-3614

Abstract

Abstract : Primary hyperparathyroidism is the most frequent manifestation of multiple endocrine neoplasia type 1 (MEN1) syndrome. Bone and renal complications are common. Surgery is the treatment of choice, but the best timing for surgery is controversial and predictors of persistence and recurrence are not well known. Our study describes the clinical characteristics and the surgical outcomes, after surgery and in the long term, of the patients with MEN1 and primary hyperparathyroidism included in the Spanish Registry of Multiple Endocrine Neoplasia, Pheochromocytomas and Paragangliomas (REGMEN). Eighty-nine patients (49 men and 40 women, 34.2 ± 13 years old) were included. Sixty-four out of the 89 underwent surgery: a total parathyroidectomy was done in 13 patients, a subtotal parathyroidectomy in 34 and a less than subtotal parathyroidectomy in 15. Remission rates were higher after a total or a subtotal parathyroidectomy than after a less than subtotal (3/4 and 20/22 vs 7/12, P < 0.05), without significant differences in permanent hypoparathyroidism (1/5, 9/23 and 0/11, N.S.). After a median follow-up of 111 months, 20 of the 41 operated patients with long-term follow-up had persistent or recurrent hyperparathyroidism. We did not find differences in disease-free survival rates between different techniques, patients with or without permanent hypoparathyroidism and patients with different mutated exons, but a second surgery was more frequent after a less than subtotal parathyroidectomy.